Scinus Cell Expansion BV, a RegMed XB partner, has made the next step in bringing solutions to patients. Prometheus at KU Leuven, Belgium, installed a novel bioreactor from Scinus Cell Expansion B.V.

Selma Kaffka genaamd Dengler, Clémence Odille, Mudit Mishra, Niels van der Kaaij, Pieter Doevensdans, Joost Sluijter and Saskia de Jager from the University Medical Center Utrecht published the paper “Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation

The Utrecht-based company TargED Biopharmaceuticals received the first start-up funding from the FIRST fund, founded by the DCVA, RegMed XB and RVO. With the support of this new investment, the company can conduct follow-up research with their compound (Microlysis) that dissolves blood clots. The potential effect of this drug in strokes was discovered at UMC Utrecht.

“Should human embryo-like structures be considered human embryos? If not, do they resemble human embryos so closely that they should still be due some moral and legal protection? If so, to what extent and in virtue of what exactly? Are there particular stages or events in embryogenesis from which synthetic embryologists should always steer away?”

Congratulations to Margot Rikkers on the publication of the paper “Importance of Timing of Platelet Lysate-Supplementation in Expanding or Redifferentiating Human Chondrocytes for Chondrogenesis” in the Preclinical Cell and Gene therapy section of Frontiers in Bioengineering and Biotechnology magazine.

Thomas Geuens, Vanessa LaPointe and Clemens van Blitterswijk from MERLN Institute of Maastricht University have published the paper “Overcoming kidney organoid challenges for regenerative medicine” discussing the recent advances and remaining challenges for kidney organoids to become successful in regenerative medicine.